Detalhe da pesquisa
1.
Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor.
Clin Cancer Res
; 28(6): 1107-1116, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34980598
2.
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study.
Eur J Cancer
; 168: 12-24, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429901
3.
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study.
Cancers (Basel)
; 13(21)2021 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771596
4.
Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD).
Clin Transl Oncol
; 11(7): 486-7, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19574209